2025-03-26 06:02:39
Latest Post
Rulka Electricals Secures 21 New Work Orders totaling Rs 12.36 Crore in March 2025
Ambo Agritec Ltd to expand presence in FMCG segment
Prism Johnson Ltd declared preferred bidder for mining lease of limestone block
Welspun Michigan Engineers Secures New Order to Upgrade the Haji Ali Storm Water Pumping Station in Mumbai
Capitalizing on Growth: Why Financial Services Firms Need a Unified AI Strategy
Stock Report
Indo US Bio-Tech Ltd Q4 FY24 profit at Rs. 52.43 lakhs
Posted On : 2024-05-03 22:49:08( TIMEZONE : IST )
Indo Us Bio-Tech Ltd has reported Standalone financial results for the period ended March 31, 2024.
Financial Results (Q4 FY2024) - QoQ Comparison
The company has reported total income of Rs. 15.9771 crores during the period ended March 31, 2024 as compared to Rs. 22.1907 crores during the period ended December 31, 2023.
The company has posted net profit / (loss) of Rs. 0.5243 crores for the period ended March 31, 2024 as against net profit / (loss) of Rs. 3.6846 crores for the period ended December 31, 2023.
The company has reported EPS of Rs. 0.26 for the period ended March 31, 2024 as compared to Rs. 1.84 for the period ended December 31, 2023.
| Financials | Q4 FY2024 | Q3 FY2024 | % Change |
| Total Income | ₹ 15.9771 crs | ₹22.1907 crs |  -28.00% |
| Net Profit | ₹0.5243 crs | ₹3.6846 crs | -85.77% |
| EPS | ₹0.26 | ₹1.84 | -85.87% |
Financial Results (Q4 FY2024) - YoY Comparison
The company has reported total income of Rs. 15.9771 crores during the period ended March 31, 2024 as compared to Rs.18.1270 crores during the period ended March 31, 2023.
The company has posted net profit / (loss) of Rs.0.5243 crores for the period ended March 31, 2024 as against net profit / (loss) of Rs.2.7722 crores for the period ended March 31, 2023.
The company has reported EPS of Rs.0.26 for the period ended March 31, 2024 as compared to Rs.1.38 for the period ended March 31, 2023.
| Financials | Q4 FY2024 | Q4 FY2023 | % Change |
| Total Income | ₹ 15.9771 crs | ₹18.1270 crs | -11.86% |
| Net Profit | ₹0.5243 crs | ₹2.7722 crs | -81.09% |
| EPS | ₹0.26 | ₹1.38 | -81.16% |
Financial Results (Year Ended FY2024) - YoY Comparison
The company has reported total income of Rs.73.1558 crores during the Financial Year ended March 31, 2024 as compared to Rs.61.7656 crores during the Financial Year ended March 31, 2023.
The company has posted net profit / (loss) of Rs.8.2514 crores for the Financial Year ended March 31, 2024 as against net profit / (loss) of Rs.7.2404 crores for the Financial Year ended March 31, 2023.
The company has reported EPS of Rs.4.11 for the Financial Year ended March 31, 2024 as compared to Rs.3.61 for the Financial Year ended March 31, 2023.
| Financials | Year Ended FY2024 | Year Ended FY2023 | % Change |
| Total Income | ₹73.1558 crs | ₹61.7656 crs |  18.44% |
| Net Profit | ₹8.2514 crs | ₹7.2404 crs | 13.96% |
| EPS | ₹4.11 | ₹3.61 | 13.85% |
Shares of Indo Us Bio-Tech Ltd was last trading in BSE at Rs. 216.65 as compared to the previous close of Rs. 223.10. The total number of shares traded during the day was 3500 in over 7 trades.
The stock hit an intraday high of Rs. 221.00 and intraday low of 214.40. The net turnover during the day was Rs. 761575.00.
